[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fCZUhQZ7zUh8ilEBcg1ibNUHpqI6c6cMyBZS2j6hs1yw":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":84,"rows":91},"Ann & Robert H Lurie Children's Hospital of Chicago",[4],181,false,51,7,41719,15,138,[14,17,19,21,24,27,29,31],{"name":15,"count":16},"Leukemia",6,{"name":18,"count":16},"Sickle Cell Disease",{"name":20,"count":16},"Eosinophilic Esophagitis",{"name":22,"count":23},"Cancer",5,{"name":25,"count":26},"Sickle Beta Zero Thalassemia",4,{"name":28,"count":26},"Sickle B+ Thalassemia",{"name":30,"count":26},"Sickle Cell Hemoglobin C",{"name":32,"count":26},"Children",[34,39,44,49,54,59,64,69,74,79],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT02096159","Prophylactic Antibiotics or Placebo After Hypospadias Repair","2018-12","trimethoprim-sulfamethoxazole",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT06149676","A Novel Probiotic-antibiotic Combination to Prevent Recurrent Urinary Tract Infections","2024-12-31","Saccharomyces Boulardii 250 MG [Florastor]",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT04598230","Partners in Caring for Anxious Youth","2025-08-31","Combination therapy",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT06235125","Safety and Feasibility of Intraoperative Visualization With Cytalux in Children","2026-01-20","Cytalux",{"nctId":55,"briefTitle":56,"date":57,"intervention":58},"NCT05815784","Myopia Control: a Comparison Study Between Atropine and MiSight","2026-03-13","Atropine",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT06430684","Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease","2026-06-01","Empagliflozin 10 MG",{"nctId":65,"briefTitle":66,"date":67,"intervention":68},"NCT04943848","rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG","2026-09","rHSC-DIPGVax",{"nctId":70,"briefTitle":71,"date":72,"intervention":73},"NCT06162494","Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients","2027-03-31","Recombinant Zoster Vaccine",{"nctId":75,"briefTitle":76,"date":77,"intervention":78},"NCT05309590","Efficacy of Low-Dose Topical Steroids in Maintaining Remission of Eosinophilic Esophagitis in Children","2027-05","Dose",{"nctId":80,"briefTitle":81,"date":82,"intervention":83},"NCT06712875","MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas","2028-12","Trametinib and Nivolumab",[85,86,87,88,89,90],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[92,117,142,167,185,209,239,260,285,303,321,346,368,391,412,433,459,487,505,531,558,576,600,625,643,693,730,755,784,810,835,853,871,889,913,937,966,984,1011,1035,1062,1090,1108,1131,1170,1196,1226,1244,1267,1291],{"intervention":73,"totalTrials":93,"cells":94},1,{"EARLY_PHASE1":95,"PHASE1":98,"PHASE2":100,"PHASE3":102,"PHASE4":104,"NA":115},{"trials":96,"activeCount":97},[],0,{"trials":99,"activeCount":97},[],{"trials":101,"activeCount":97},[],{"trials":103,"activeCount":97},[],{"trials":105,"activeCount":93,"soonestReadout":72},[106],{"nctId":70,"briefTitle":71,"status":107,"phases":108,"primaryCompletion":72,"completion":109,"start":110,"enrollment":111,"conditions":112,"interventions":114},"ENROLLING_BY_INVITATION",[89],"2028-09-30","2024-03-18",80,[113],"Varicella Zoster",[73],{"trials":116,"activeCount":97},[],{"intervention":48,"totalTrials":93,"cells":118},{"EARLY_PHASE1":119,"PHASE1":121,"PHASE2":123,"PHASE3":125,"PHASE4":138,"NA":140},{"trials":120,"activeCount":97},[],{"trials":122,"activeCount":97},[],{"trials":124,"activeCount":97},[],{"trials":126,"activeCount":93,"soonestReadout":47},[127],{"nctId":45,"briefTitle":46,"status":128,"phases":129,"primaryCompletion":47,"completion":130,"start":131,"enrollment":132,"conditions":133,"interventions":137},"ACTIVE_NOT_RECRUITING",[88],"2026-12-31","2021-02-09",468,[134,135,136],"Anxiety, Separation","Anxiety, Generalized","Anxiety, Social",[48],{"trials":139,"activeCount":97},[],{"trials":141,"activeCount":97},[],{"intervention":83,"totalTrials":93,"cells":143},{"EARLY_PHASE1":144,"PHASE1":146,"PHASE2":148,"PHASE3":161,"PHASE4":163,"NA":165},{"trials":145,"activeCount":97},[],{"trials":147,"activeCount":97},[],{"trials":149,"activeCount":93,"soonestReadout":82},[150],{"nctId":80,"briefTitle":81,"status":151,"phases":152,"primaryCompletion":82,"completion":153,"start":154,"enrollment":155,"conditions":156,"interventions":159},"RECRUITING",[86,87],"2029-06","2025-04-01",27,[157,158],"Low Grade Glioma","High Grade Glioma",[83,160],"Dabrafenib, trametinib, nivolumab",{"trials":162,"activeCount":97},[],{"trials":164,"activeCount":97},[],{"trials":166,"activeCount":97},[],{"intervention":160,"totalTrials":93,"cells":168},{"EARLY_PHASE1":169,"PHASE1":171,"PHASE2":173,"PHASE3":179,"PHASE4":181,"NA":183},{"trials":170,"activeCount":97},[],{"trials":172,"activeCount":97},[],{"trials":174,"activeCount":93,"soonestReadout":82},[175],{"nctId":80,"briefTitle":81,"status":151,"phases":176,"primaryCompletion":82,"completion":153,"start":154,"enrollment":155,"conditions":177,"interventions":178},[86,87],[157,158],[83,160],{"trials":180,"activeCount":97},[],{"trials":182,"activeCount":97},[],{"trials":184,"activeCount":97},[],{"intervention":186,"totalTrials":93,"cells":187},"Tylenol",{"EARLY_PHASE1":188,"PHASE1":190,"PHASE2":192,"PHASE3":203,"PHASE4":205,"NA":207},{"trials":189,"activeCount":97},[],{"trials":191,"activeCount":97},[],{"trials":193,"activeCount":93,"soonestReadout":199},[194],{"nctId":195,"briefTitle":196,"status":197,"phases":198,"primaryCompletion":199,"completion":199,"start":154,"enrollment":111,"conditions":200,"interventions":202},"NCT06689943","Pain After Strabismus Surgery","NOT_YET_RECRUITING",[87],"2028-12-31",[201],"Strabismus",[186],{"trials":204,"activeCount":97},[],{"trials":206,"activeCount":97},[],{"trials":208,"activeCount":97},[],{"intervention":210,"totalTrials":93,"cells":211},"Anakinra",{"EARLY_PHASE1":212,"PHASE1":214,"PHASE2":216,"PHASE3":233,"PHASE4":235,"NA":237},{"trials":213,"activeCount":97},[],{"trials":215,"activeCount":97},[],{"trials":217,"activeCount":93,"soonestReadout":222},[218],{"nctId":219,"briefTitle":220,"status":197,"phases":221,"primaryCompletion":222,"completion":223,"start":224,"enrollment":225,"conditions":226,"interventions":232},"NCT06703216","Pre-emptive Anakinra for Cytokine Event Reduction",[86,87],"2029-08-31","2030-02-28","2025-08",24,[227,228,229,230,231],"B-Acute Lymphoblastic Leukemia","CAR-T Cell Therapy","Cytokine Release Syndrome","Immune Effector Cell Associated Neurotoxicity Syndrome","Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome",[210],{"trials":234,"activeCount":97},[],{"trials":236,"activeCount":97},[],{"trials":238,"activeCount":97},[],{"intervention":58,"totalTrials":93,"cells":240},{"EARLY_PHASE1":241,"PHASE1":243,"PHASE2":245,"PHASE3":254,"PHASE4":256,"NA":258},{"trials":242,"activeCount":97},[],{"trials":244,"activeCount":97},[],{"trials":246,"activeCount":93,"soonestReadout":57},[247],{"nctId":55,"briefTitle":56,"status":151,"phases":248,"primaryCompletion":57,"completion":57,"start":249,"enrollment":250,"conditions":251,"interventions":253},[87],"2023-05-02",348,[252],"Myopia",[58],{"trials":255,"activeCount":97},[],{"trials":257,"activeCount":97},[],{"trials":259,"activeCount":97},[],{"intervention":68,"totalTrials":93,"cells":261},{"EARLY_PHASE1":262,"PHASE1":264,"PHASE2":277,"PHASE3":279,"PHASE4":281,"NA":283},{"trials":263,"activeCount":97},[],{"trials":265,"activeCount":93,"soonestReadout":67},[266],{"nctId":65,"briefTitle":66,"status":151,"phases":267,"primaryCompletion":67,"completion":268,"start":269,"enrollment":270,"conditions":271,"interventions":274},[86],"2027-09","2022-01-10",36,[272,273],"Diffuse Intrinsic Pontine Glioma","Diffuse Midline Glioma, H3 K27M-Mutant",[68,275,276],"Balstilimab","Zalifrelimab",{"trials":278,"activeCount":97},[],{"trials":280,"activeCount":97},[],{"trials":282,"activeCount":97},[],{"trials":284,"activeCount":97},[],{"intervention":275,"totalTrials":93,"cells":286},{"EARLY_PHASE1":287,"PHASE1":289,"PHASE2":295,"PHASE3":297,"PHASE4":299,"NA":301},{"trials":288,"activeCount":97},[],{"trials":290,"activeCount":93,"soonestReadout":67},[291],{"nctId":65,"briefTitle":66,"status":151,"phases":292,"primaryCompletion":67,"completion":268,"start":269,"enrollment":270,"conditions":293,"interventions":294},[86],[272,273],[68,275,276],{"trials":296,"activeCount":97},[],{"trials":298,"activeCount":97},[],{"trials":300,"activeCount":97},[],{"trials":302,"activeCount":97},[],{"intervention":276,"totalTrials":93,"cells":304},{"EARLY_PHASE1":305,"PHASE1":307,"PHASE2":313,"PHASE3":315,"PHASE4":317,"NA":319},{"trials":306,"activeCount":97},[],{"trials":308,"activeCount":93,"soonestReadout":67},[309],{"nctId":65,"briefTitle":66,"status":151,"phases":310,"primaryCompletion":67,"completion":268,"start":269,"enrollment":270,"conditions":311,"interventions":312},[86],[272,273],[68,275,276],{"trials":314,"activeCount":97},[],{"trials":316,"activeCount":97},[],{"trials":318,"activeCount":97},[],{"trials":320,"activeCount":97},[],{"intervention":53,"totalTrials":93,"cells":322},{"EARLY_PHASE1":323,"PHASE1":325,"PHASE2":338,"PHASE3":340,"PHASE4":342,"NA":344},{"trials":324,"activeCount":97},[],{"trials":326,"activeCount":93,"soonestReadout":52},[327],{"nctId":50,"briefTitle":51,"status":151,"phases":328,"primaryCompletion":52,"completion":52,"start":329,"enrollment":330,"conditions":331,"interventions":337},[86],"2024-04-08",10,[332,333,334,335,336],"Osteosarcoma","Pulmonary Metastasis","Fluorescence","Metastatic Sarcoma","Pediatrics",[53],{"trials":339,"activeCount":97},[],{"trials":341,"activeCount":97},[],{"trials":343,"activeCount":97},[],{"trials":345,"activeCount":97},[],{"intervention":43,"totalTrials":93,"cells":347},{"EARLY_PHASE1":348,"PHASE1":358,"PHASE2":360,"PHASE3":362,"PHASE4":364,"NA":366},{"trials":349,"activeCount":93,"soonestReadout":42},[350],{"nctId":40,"briefTitle":41,"status":151,"phases":351,"primaryCompletion":42,"completion":352,"start":353,"enrollment":354,"conditions":355,"interventions":357},[85],"2025-12-31","2022-02-02",35,[356],"Recurrent Uti",[43],{"trials":359,"activeCount":97},[],{"trials":361,"activeCount":97},[],{"trials":363,"activeCount":97},[],{"trials":365,"activeCount":97},[],{"trials":367,"activeCount":97},[],{"intervention":63,"totalTrials":93,"cells":369},{"EARLY_PHASE1":370,"PHASE1":381,"PHASE2":383,"PHASE3":385,"PHASE4":387,"NA":389},{"trials":371,"activeCount":93,"soonestReadout":62},[372],{"nctId":60,"briefTitle":61,"status":151,"phases":373,"primaryCompletion":62,"completion":374,"start":375,"enrollment":376,"conditions":377,"interventions":380},[85],"2026-07-01","2024-08-23",40,[378,379],"Chronic Kidney Diseases","Pediatric Kidney Disease",[63],{"trials":382,"activeCount":97},[],{"trials":384,"activeCount":97},[],{"trials":386,"activeCount":97},[],{"trials":388,"activeCount":97},[],{"trials":390,"activeCount":97},[],{"intervention":78,"totalTrials":93,"cells":392},{"EARLY_PHASE1":393,"PHASE1":395,"PHASE2":397,"PHASE3":399,"PHASE4":401,"NA":403},{"trials":394,"activeCount":97},[],{"trials":396,"activeCount":97},[],{"trials":398,"activeCount":97},[],{"trials":400,"activeCount":97},[],{"trials":402,"activeCount":97},[],{"trials":404,"activeCount":93,"soonestReadout":77},[405],{"nctId":75,"briefTitle":76,"status":128,"phases":406,"primaryCompletion":77,"completion":407,"start":408,"enrollment":409,"conditions":410,"interventions":411},[],"2027-11","2014-05",50,[20],[78],{"intervention":38,"totalTrials":93,"cells":413},{"EARLY_PHASE1":414,"PHASE1":416,"PHASE2":418,"PHASE3":420,"PHASE4":422,"NA":424},{"trials":415,"activeCount":97},[],{"trials":417,"activeCount":97},[],{"trials":419,"activeCount":97},[],{"trials":421,"activeCount":97},[],{"trials":423,"activeCount":97},[],{"trials":425,"activeCount":93,"soonestReadout":37},[426],{"nctId":35,"briefTitle":36,"status":128,"phases":427,"primaryCompletion":37,"completion":224,"start":428,"enrollment":429,"conditions":430,"interventions":432},[90],"2014-03",93,[431],"Hypospadias",[38],{"intervention":434,"totalTrials":93,"cells":435},"Amitriptyline",{"EARLY_PHASE1":436,"PHASE1":438,"PHASE2":440,"PHASE3":442,"PHASE4":444,"NA":457},{"trials":437,"activeCount":97},[],{"trials":439,"activeCount":97},[],{"trials":441,"activeCount":97},[],{"trials":443,"activeCount":97},[],{"trials":445,"activeCount":97},[446],{"nctId":447,"briefTitle":448,"status":449,"phases":450,"completion":451,"start":452,"enrollment":453,"conditions":454,"interventions":456},"NCT00564525","Study of Medication for Functional Abdominal Pain in Children","COMPLETED",[89],"2007-06","2002-10",95,[455],"Functional Gastrointestinal Disorders",[434],{"trials":458,"activeCount":97},[],{"intervention":460,"totalTrials":93,"cells":461},"Zidovudine",{"EARLY_PHASE1":462,"PHASE1":464,"PHASE2":466,"PHASE3":468,"PHASE4":470,"NA":485},{"trials":463,"activeCount":97},[],{"trials":465,"activeCount":97},[],{"trials":467,"activeCount":97},[],{"trials":469,"activeCount":97},[],{"trials":471,"activeCount":97},[472],{"nctId":473,"briefTitle":474,"status":449,"phases":475,"primaryCompletion":476,"completion":476,"start":477,"enrollment":478,"conditions":479,"interventions":483},"NCT03088410","Study of HIV-Infected and Uninfected Pregnant Woman\u002FChild Dyads in Gaborone, Botswana",[89],"2022-03-31","2016-08-22",495,[480,481,482],"HIV","Insulin Sensitivity","Diabetes Mellitus",[460,484],"Nevirapine",{"trials":486,"activeCount":97},[],{"intervention":484,"totalTrials":93,"cells":488},{"EARLY_PHASE1":489,"PHASE1":491,"PHASE2":493,"PHASE3":495,"PHASE4":497,"NA":503},{"trials":490,"activeCount":97},[],{"trials":492,"activeCount":97},[],{"trials":494,"activeCount":97},[],{"trials":496,"activeCount":97},[],{"trials":498,"activeCount":97},[499],{"nctId":473,"briefTitle":474,"status":449,"phases":500,"primaryCompletion":476,"completion":476,"start":477,"enrollment":478,"conditions":501,"interventions":502},[89],[480,481,482],[460,484],{"trials":504,"activeCount":97},[],{"intervention":506,"totalTrials":93,"cells":507},"Crisaborole",{"EARLY_PHASE1":508,"PHASE1":510,"PHASE2":512,"PHASE3":514,"PHASE4":516,"NA":529},{"trials":509,"activeCount":97},[],{"trials":511,"activeCount":97},[],{"trials":513,"activeCount":97},[],{"trials":515,"activeCount":97},[],{"trials":517,"activeCount":97},[518],{"nctId":519,"briefTitle":520,"status":449,"phases":521,"primaryCompletion":522,"completion":522,"start":523,"enrollment":524,"conditions":525,"interventions":528},"NCT04023084","Response of Children With Atopic Dermatitis (Eczema) to Eucrisa",[89],"2022-02-11","2019-10-03",30,[526,527],"Atopic Dermatitis","Eczema",[506],{"trials":530,"activeCount":97},[],{"intervention":532,"totalTrials":93,"cells":533},"Lidocaine",{"EARLY_PHASE1":534,"PHASE1":536,"PHASE2":538,"PHASE3":540,"PHASE4":554,"NA":556},{"trials":535,"activeCount":97},[],{"trials":537,"activeCount":97},[],{"trials":539,"activeCount":97},[],{"trials":541,"activeCount":97},[542],{"nctId":543,"briefTitle":544,"status":449,"phases":545,"primaryCompletion":546,"completion":547,"start":548,"enrollment":549,"conditions":550,"interventions":552},"NCT02595463","Intravenous Lidocaine for Post-Tonsillectomy Pain in Pediatric Patients",[87,88],"2024-06-05","2024-07-05","2015-11",89,[551],"Pain",[532,553],"Saline",{"trials":555,"activeCount":97},[],{"trials":557,"activeCount":97},[],{"intervention":553,"totalTrials":93,"cells":559},{"EARLY_PHASE1":560,"PHASE1":562,"PHASE2":564,"PHASE3":566,"PHASE4":572,"NA":574},{"trials":561,"activeCount":97},[],{"trials":563,"activeCount":97},[],{"trials":565,"activeCount":97},[],{"trials":567,"activeCount":97},[568],{"nctId":543,"briefTitle":544,"status":449,"phases":569,"primaryCompletion":546,"completion":547,"start":548,"enrollment":549,"conditions":570,"interventions":571},[87,88],[551],[532,553],{"trials":573,"activeCount":97},[],{"trials":575,"activeCount":97},[],{"intervention":577,"totalTrials":93,"cells":578},"Iron Sulfate",{"EARLY_PHASE1":579,"PHASE1":581,"PHASE2":583,"PHASE3":585,"PHASE4":596,"NA":598},{"trials":580,"activeCount":97},[],{"trials":582,"activeCount":97},[],{"trials":584,"activeCount":97},[],{"trials":586,"activeCount":97},[587],{"nctId":588,"briefTitle":589,"status":449,"phases":590,"primaryCompletion":591,"completion":591,"start":592,"enrollment":8,"conditions":593,"interventions":595},"NCT04691843","Iron Supplementation and Neurodevelopmental Outcome in ELGANs",[88],"2024-08-31","2021-02-01",[594],"Iron-deficiency",[577],{"trials":597,"activeCount":97},[],{"trials":599,"activeCount":97},[],{"intervention":601,"totalTrials":93,"cells":602},"Magnesium",{"EARLY_PHASE1":603,"PHASE1":605,"PHASE2":607,"PHASE3":609,"PHASE4":621,"NA":623},{"trials":604,"activeCount":97},[],{"trials":606,"activeCount":97},[],{"trials":608,"activeCount":97},[],{"trials":610,"activeCount":97},[611],{"nctId":612,"briefTitle":613,"status":449,"phases":614,"primaryCompletion":615,"completion":615,"start":616,"enrollment":617,"conditions":618,"interventions":619},"NCT02218424","Magnesium vs Placebo for Tonsillectomy",[87,88],"2015-04","2014-10",60,[551],[601,620],"Normal saline",{"trials":622,"activeCount":97},[],{"trials":624,"activeCount":97},[],{"intervention":620,"totalTrials":93,"cells":626},{"EARLY_PHASE1":627,"PHASE1":629,"PHASE2":631,"PHASE3":633,"PHASE4":639,"NA":641},{"trials":628,"activeCount":97},[],{"trials":630,"activeCount":97},[],{"trials":632,"activeCount":97},[],{"trials":634,"activeCount":97},[635],{"nctId":612,"briefTitle":613,"status":449,"phases":636,"primaryCompletion":615,"completion":615,"start":616,"enrollment":617,"conditions":637,"interventions":638},[87,88],[551],[601,620],{"trials":640,"activeCount":97},[],{"trials":642,"activeCount":97},[],{"intervention":644,"totalTrials":645,"cells":646},"Carboplatin",3,{"EARLY_PHASE1":647,"PHASE1":649,"PHASE2":651,"PHASE3":687,"PHASE4":689,"NA":691},{"trials":648,"activeCount":97},[],{"trials":650,"activeCount":97},[],{"trials":652,"activeCount":97},[653,664,675],{"nctId":654,"briefTitle":655,"status":449,"phases":656,"completion":657,"start":658,"enrollment":524,"conditions":659,"interventions":662},"NCT00179920","Chemotherapy Treatment for Children With Intraocular Germ-Line Retinoblastoma",[87],"2006-09","1996-04",[660,661],"Retinoblastoma","Retinal Neoplasms",[644,663],"VP-16",{"nctId":665,"briefTitle":666,"status":667,"phases":668,"primaryCompletion":669,"completion":615,"start":670,"enrollment":671,"conditions":672,"interventions":674},"NCT01088035","Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma","TERMINATED",[87],"2015-01","2010-04",75,[673],"Ependymoma",[644],{"nctId":676,"briefTitle":677,"status":449,"phases":678,"primaryCompletion":679,"completion":679,"start":680,"enrollment":681,"conditions":682,"interventions":685},"NCT00179881","Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma",[87],"2007-04","1999-12",47,[683,684],"Brain Stem Neoplasms, Primary","Neoplasms, Brain Stem",[644,686],"Thalomid",{"trials":688,"activeCount":97},[],{"trials":690,"activeCount":97},[],{"trials":692,"activeCount":97},[],{"intervention":694,"totalTrials":695,"cells":696},"Busulfan",2,{"EARLY_PHASE1":697,"PHASE1":699,"PHASE2":711,"PHASE3":724,"PHASE4":726,"NA":728},{"trials":698,"activeCount":97},[],{"trials":700,"activeCount":97},[701],{"nctId":702,"briefTitle":703,"status":704,"phases":705,"primaryCompletion":706,"completion":706,"start":707,"enrollment":97,"conditions":708,"interventions":710},"NCT00836628","Study of Busulfan for Refractory Central Nervous System (CNS) Tumors","WITHDRAWN",[86],"2010-10","2008-07",[709],"Refractory Brain Tumors",[694],{"trials":712,"activeCount":97},[713],{"nctId":714,"briefTitle":715,"status":716,"phases":717,"primaryCompletion":718,"completion":718,"start":719,"enrollment":524,"conditions":720,"interventions":721},"NCT00679536","Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors","UNKNOWN",[86,87],"2015-05","2008-05",[15],[694,722,723],"Fludarabine","Thymoglobulin",{"trials":725,"activeCount":97},[],{"trials":727,"activeCount":97},[],{"trials":729,"activeCount":97},[],{"intervention":731,"totalTrials":93,"cells":732},"Conditioning Regimen & GVHD Prophylaxis",{"EARLY_PHASE1":733,"PHASE1":735,"PHASE2":737,"PHASE3":749,"PHASE4":751,"NA":753},{"trials":734,"activeCount":97},[],{"trials":736,"activeCount":97},[],{"trials":738,"activeCount":97},[739],{"nctId":740,"briefTitle":741,"status":704,"phases":742,"primaryCompletion":743,"completion":743,"start":744,"enrollment":97,"conditions":745,"interventions":748},"NCT02053545","Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w\u002FPost-Transplant In-Vivo T-cell Depletion",[86,87],"2017-05-11","2013-12",[15,746,747],"Lymphoma","MDS",[731],{"trials":750,"activeCount":97},[],{"trials":752,"activeCount":97},[],{"trials":754,"activeCount":97},[],{"intervention":756,"totalTrials":93,"cells":757},"0.25% Bupivacaine + Clonidine",{"EARLY_PHASE1":758,"PHASE1":760,"PHASE2":762,"PHASE3":778,"PHASE4":780,"NA":782},{"trials":759,"activeCount":97},[],{"trials":761,"activeCount":97},[],{"trials":763,"activeCount":97},[764],{"nctId":765,"briefTitle":766,"status":449,"phases":767,"primaryCompletion":768,"completion":769,"start":770,"enrollment":771,"conditions":772,"interventions":777},"NCT01638052","Great Auricular Nerve Block for Children Undergoing Tympanomastoid Surgery",[87],"2008-03","2008-04","2006-02",56,[773,774,775,776],"Tympanomastoid Surgery","Cochlear Implant","Mastoidectomy","Cholesteatoma",[756],{"trials":779,"activeCount":97},[],{"trials":781,"activeCount":97},[],{"trials":783,"activeCount":97},[],{"intervention":785,"totalTrials":93,"cells":786},"Fludarabine, Busulfan, and Anti-Thymocyte Globulin",{"EARLY_PHASE1":787,"PHASE1":789,"PHASE2":791,"PHASE3":804,"PHASE4":806,"NA":808},{"trials":788,"activeCount":97},[],{"trials":790,"activeCount":97},[],{"trials":792,"activeCount":97},[793],{"nctId":794,"briefTitle":795,"status":716,"phases":796,"primaryCompletion":797,"completion":798,"start":799,"enrollment":800,"conditions":801,"interventions":803},"NCT00613561","Early Diagnosis and Stem Cell Transplantation for Severe Immunodeficiency Diseases",[87],"2012-12","2017-12","2007-12",25,[802],"Severe Immunodeficiency Diseases",[785],{"trials":805,"activeCount":97},[],{"trials":807,"activeCount":97},[],{"trials":809,"activeCount":97},[],{"intervention":811,"totalTrials":93,"cells":812},"Ibrutinib",{"EARLY_PHASE1":813,"PHASE1":815,"PHASE2":817,"PHASE3":829,"PHASE4":831,"NA":833},{"trials":814,"activeCount":97},[],{"trials":816,"activeCount":97},[],{"trials":818,"activeCount":97},[819],{"nctId":820,"briefTitle":821,"status":449,"phases":822,"primaryCompletion":823,"completion":823,"start":824,"enrollment":16,"conditions":825,"interventions":828},"NCT03149315","Inhibition of Anaphylaxis by Ibrutinib",[87],"2018-11-14","2017-04-10",[826,827],"Food Allergy","Anaphylaxis Food",[811],{"trials":830,"activeCount":97},[],{"trials":832,"activeCount":97},[],{"trials":834,"activeCount":97},[],{"intervention":663,"totalTrials":93,"cells":836},{"EARLY_PHASE1":837,"PHASE1":839,"PHASE2":841,"PHASE3":847,"PHASE4":849,"NA":851},{"trials":838,"activeCount":97},[],{"trials":840,"activeCount":97},[],{"trials":842,"activeCount":97},[843],{"nctId":654,"briefTitle":655,"status":449,"phases":844,"completion":657,"start":658,"enrollment":524,"conditions":845,"interventions":846},[87],[660,661],[644,663],{"trials":848,"activeCount":97},[],{"trials":850,"activeCount":97},[],{"trials":852,"activeCount":97},[],{"intervention":722,"totalTrials":93,"cells":854},{"EARLY_PHASE1":855,"PHASE1":857,"PHASE2":859,"PHASE3":865,"PHASE4":867,"NA":869},{"trials":856,"activeCount":97},[],{"trials":858,"activeCount":97},[],{"trials":860,"activeCount":97},[861],{"nctId":714,"briefTitle":715,"status":716,"phases":862,"primaryCompletion":718,"completion":718,"start":719,"enrollment":524,"conditions":863,"interventions":864},[86,87],[15],[694,722,723],{"trials":866,"activeCount":97},[],{"trials":868,"activeCount":97},[],{"trials":870,"activeCount":97},[],{"intervention":723,"totalTrials":93,"cells":872},{"EARLY_PHASE1":873,"PHASE1":875,"PHASE2":877,"PHASE3":883,"PHASE4":885,"NA":887},{"trials":874,"activeCount":97},[],{"trials":876,"activeCount":97},[],{"trials":878,"activeCount":97},[879],{"nctId":714,"briefTitle":715,"status":716,"phases":880,"primaryCompletion":718,"completion":718,"start":719,"enrollment":524,"conditions":881,"interventions":882},[86,87],[15],[694,722,723],{"trials":884,"activeCount":97},[],{"trials":886,"activeCount":97},[],{"trials":888,"activeCount":97},[],{"intervention":890,"totalTrials":93,"cells":891},"Pentostatin",{"EARLY_PHASE1":892,"PHASE1":894,"PHASE2":896,"PHASE3":907,"PHASE4":909,"NA":911},{"trials":893,"activeCount":97},[],{"trials":895,"activeCount":97},[],{"trials":897,"activeCount":97},[898],{"nctId":899,"briefTitle":900,"status":449,"phases":901,"primaryCompletion":902,"completion":902,"start":903,"enrollment":617,"conditions":904,"interventions":906},"NCT00144430","Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children",[87],"2008-08","2004-01",[905],"Graft vs Host Disease",[890],{"trials":908,"activeCount":97},[],{"trials":910,"activeCount":97},[],{"trials":912,"activeCount":97},[],{"intervention":914,"totalTrials":93,"cells":915},"Prednisone",{"EARLY_PHASE1":916,"PHASE1":918,"PHASE2":920,"PHASE3":931,"PHASE4":933,"NA":935},{"trials":917,"activeCount":97},[],{"trials":919,"activeCount":97},[],{"trials":921,"activeCount":97},[922],{"nctId":923,"briefTitle":924,"status":704,"phases":925,"primaryCompletion":926,"completion":926,"start":927,"enrollment":97,"conditions":928,"interventions":930},"NCT02036463","A Trial of Chronotherapy of Corticosteroids in Duchenne Muscular Dystrophy",[87],"2015-02","2014-11",[929],"Duchenne Muscular Dystrophy (DMD)",[914],{"trials":932,"activeCount":97},[],{"trials":934,"activeCount":97},[],{"trials":936,"activeCount":97},[],{"intervention":938,"totalTrials":93,"cells":939},"High-Dose Chemotherapy with Tandem PBSC Rescue.",{"EARLY_PHASE1":940,"PHASE1":942,"PHASE2":944,"PHASE3":960,"PHASE4":962,"NA":964},{"trials":941,"activeCount":97},[],{"trials":943,"activeCount":97},[],{"trials":945,"activeCount":97},[946],{"nctId":947,"briefTitle":948,"status":716,"phases":949,"primaryCompletion":950,"completion":950,"start":951,"enrollment":952,"conditions":953,"interventions":959},"NCT00179816","Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors",[86,87],"2012-09","1999-04",12,[954,955,956,957,958],"Ewing's Sarcoma","Soft Tissue Sarcoma","Hepatoblastoma","Hodgkin's Disease","Germ Cell Tumor",[938],{"trials":961,"activeCount":97},[],{"trials":963,"activeCount":97},[],{"trials":965,"activeCount":97},[],{"intervention":686,"totalTrials":93,"cells":967},{"EARLY_PHASE1":968,"PHASE1":970,"PHASE2":972,"PHASE3":978,"PHASE4":980,"NA":982},{"trials":969,"activeCount":97},[],{"trials":971,"activeCount":97},[],{"trials":973,"activeCount":97},[974],{"nctId":676,"briefTitle":677,"status":449,"phases":975,"primaryCompletion":679,"completion":679,"start":680,"enrollment":681,"conditions":976,"interventions":977},[87],[683,684],[644,686],{"trials":979,"activeCount":97},[],{"trials":981,"activeCount":97},[],{"trials":983,"activeCount":97},[],{"intervention":985,"totalTrials":93,"cells":986},"Natural Treatment",{"EARLY_PHASE1":987,"PHASE1":989,"PHASE2":991,"PHASE3":1005,"PHASE4":1007,"NA":1009},{"trials":988,"activeCount":97},[],{"trials":990,"activeCount":97},[],{"trials":992,"activeCount":97},[993],{"nctId":994,"briefTitle":995,"status":449,"phases":996,"primaryCompletion":997,"completion":998,"start":999,"enrollment":1000,"conditions":1001,"interventions":1004},"NCT03830177","Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult",[86,87],"2023-01-11","2023-10-04","2019-07-08",77,[1002,1003],"Dermatitis, Seborrheic","Dry Skin; Eczema",[985],{"trials":1006,"activeCount":97},[],{"trials":1008,"activeCount":97},[],{"trials":1010,"activeCount":97},[],{"intervention":1012,"totalTrials":93,"cells":1013},"Hydroxyurea",{"EARLY_PHASE1":1014,"PHASE1":1016,"PHASE2":1018,"PHASE3":1029,"PHASE4":1031,"NA":1033},{"trials":1015,"activeCount":97},[],{"trials":1017,"activeCount":97},[],{"trials":1019,"activeCount":97},[1020],{"nctId":1021,"briefTitle":1022,"status":667,"phases":1023,"primaryCompletion":1024,"completion":1024,"start":1025,"enrollment":16,"conditions":1026,"interventions":1028},"NCT00350844","Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension",[86,87],"2008-06","2006-07",[18,1027],"Pulmonary Hypertension",[1012],{"trials":1030,"activeCount":97},[],{"trials":1032,"activeCount":97},[],{"trials":1034,"activeCount":97},[],{"intervention":1036,"totalTrials":93,"cells":1037},"Heat Shock Protein Peptide Complex-96",{"EARLY_PHASE1":1038,"PHASE1":1040,"PHASE2":1054,"PHASE3":1056,"PHASE4":1058,"NA":1060},{"trials":1039,"activeCount":97},[],{"trials":1041,"activeCount":97},[1042],{"nctId":1043,"briefTitle":1044,"status":667,"phases":1045,"primaryCompletion":1046,"completion":1046,"start":1047,"enrollment":330,"conditions":1048,"interventions":1053},"NCT02722512","Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine",[86],"2019-11-13","2016-07",[1049,1050,1051,1052,673],"Glioblastoma Multiforme","Astrocytoma, Grade III","Anaplastic Ependymoma","Clear Cell Ependymoma",[1036],{"trials":1055,"activeCount":97},[],{"trials":1057,"activeCount":97},[],{"trials":1059,"activeCount":97},[],{"trials":1061,"activeCount":97},[],{"intervention":1063,"totalTrials":93,"cells":1064},"Supportive Care + Amoxicillin",{"EARLY_PHASE1":1065,"PHASE1":1080,"PHASE2":1082,"PHASE3":1084,"PHASE4":1086,"NA":1088},{"trials":1066,"activeCount":97},[1067],{"nctId":1068,"briefTitle":1069,"status":449,"phases":1070,"primaryCompletion":1071,"completion":1071,"start":1072,"enrollment":695,"conditions":1073,"interventions":1078},"NCT05726253","Supportive Treatment and Antibiotics for Mild Pediatric Pneumonia",[85],"2023-12-31","2023-01-09",[1074,1075,1076,1077],"Pneumonia","Pediatric Respiratory Diseases","Antibiotic Use","Community-acquired Pneumonia",[1063,1079],"Supportive Care + Placebo",{"trials":1081,"activeCount":97},[],{"trials":1083,"activeCount":97},[],{"trials":1085,"activeCount":97},[],{"trials":1087,"activeCount":97},[],{"trials":1089,"activeCount":97},[],{"intervention":1079,"totalTrials":93,"cells":1091},{"EARLY_PHASE1":1092,"PHASE1":1098,"PHASE2":1100,"PHASE3":1102,"PHASE4":1104,"NA":1106},{"trials":1093,"activeCount":97},[1094],{"nctId":1068,"briefTitle":1069,"status":449,"phases":1095,"primaryCompletion":1071,"completion":1071,"start":1072,"enrollment":695,"conditions":1096,"interventions":1097},[85],[1074,1075,1076,1077],[1063,1079],{"trials":1099,"activeCount":97},[],{"trials":1101,"activeCount":97},[],{"trials":1103,"activeCount":97},[],{"trials":1105,"activeCount":97},[],{"trials":1107,"activeCount":97},[],{"intervention":1109,"totalTrials":93,"cells":1110},"Amoxicillin",{"EARLY_PHASE1":1111,"PHASE1":1121,"PHASE2":1123,"PHASE3":1125,"PHASE4":1127,"NA":1129},{"trials":1112,"activeCount":97},[1113],{"nctId":1114,"briefTitle":1115,"status":449,"phases":1116,"primaryCompletion":1117,"completion":1117,"start":1118,"enrollment":23,"conditions":1119,"interventions":1120},"NCT04963764","Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia",[85],"2022-05-27","2021-10-18",[1074,1075,1076,1077],[1109],{"trials":1122,"activeCount":97},[],{"trials":1124,"activeCount":97},[],{"trials":1126,"activeCount":97},[],{"trials":1128,"activeCount":97},[],{"trials":1130,"activeCount":97},[],{"intervention":1132,"totalTrials":645,"cells":1133},"Bupivacaine",{"EARLY_PHASE1":1134,"PHASE1":1136,"PHASE2":1138,"PHASE3":1157,"PHASE4":1159,"NA":1161},{"trials":1135,"activeCount":97},[],{"trials":1137,"activeCount":97},[],{"trials":1139,"activeCount":97},[1140,1149],{"nctId":1141,"briefTitle":1142,"status":449,"phases":1143,"primaryCompletion":1144,"start":719,"enrollment":1145,"conditions":1146,"interventions":1148},"NCT01662401","Postoperative Pain Control in Children Undergoing Laparoscopic Appendectomy: Peripheral Nerve Block Versus Local Anesthetic",[87],"2010-01",66,[1147],"Postoperative Pain",[1132,1132],{"nctId":1150,"briefTitle":1151,"status":449,"phases":1152,"primaryCompletion":1153,"start":1154,"enrollment":270,"conditions":1155,"interventions":1156},"NCT01559740","Transversus Abdominis Plane Blocks for Infants and Children for Postoperative Pain Control",[87],"2010-08","2010-07",[1147],[1132],{"trials":1158,"activeCount":97},[],{"trials":1160,"activeCount":97},[],{"trials":1162,"activeCount":97},[1163],{"nctId":1164,"briefTitle":1165,"status":449,"phases":1166,"primaryCompletion":1167,"completion":1167,"start":1154,"enrollment":330,"conditions":1168,"interventions":1169},"NCT01557985","Single Dose Pharmacokinetics and Pharmacodynamics of Bupivacaine Following Transversus Abdominis Plane (TAP) Block in Neonates",[],"2011-10",[1147],[1132],{"intervention":1171,"totalTrials":93,"cells":1172},"IOHEXOL",{"EARLY_PHASE1":1173,"PHASE1":1175,"PHASE2":1177,"PHASE3":1179,"PHASE4":1181,"NA":1183},{"trials":1174,"activeCount":97},[],{"trials":1176,"activeCount":97},[],{"trials":1178,"activeCount":97},[],{"trials":1180,"activeCount":97},[],{"trials":1182,"activeCount":97},[],{"trials":1184,"activeCount":97},[1185],{"nctId":1186,"briefTitle":1187,"status":449,"phases":1188,"primaryCompletion":1189,"completion":1190,"start":1191,"enrollment":1192,"conditions":1193,"interventions":1195},"NCT02133599","Prediction of Excretion and Toxicity of High Dose Methotrexate in Children and Adolescents With ALL",[90],"2019-02-26","2019-02-27","2014-07-24",23,[1194],"ALL",[1171],{"intervention":1197,"totalTrials":93,"cells":1198},"Myeloablative Chemotherapy Regimen for Lymphoid Malignancies or Cord Blood Unit Recipients",{"EARLY_PHASE1":1199,"PHASE1":1201,"PHASE2":1203,"PHASE3":1205,"PHASE4":1207,"NA":1209},{"trials":1200,"activeCount":97},[],{"trials":1202,"activeCount":97},[],{"trials":1204,"activeCount":97},[],{"trials":1206,"activeCount":97},[],{"trials":1208,"activeCount":97},[],{"trials":1210,"activeCount":97},[1211],{"nctId":1212,"briefTitle":1213,"status":449,"phases":1214,"primaryCompletion":1215,"completion":1215,"start":1216,"enrollment":1217,"conditions":1218,"interventions":1224},"NCT00619879","Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies",[],"2019-02-07","2007-03-26",81,[1219,1220,1221,1222,1223],"Leukemia, Myelogenous, Chronic","Leukemia, Lymphoblastic, Acute","Leukemia, Myelogenous, Acute","Myeloproliferative-Myelodysplastic Diseases","Lymphoma, Malignant",[1197,1225],"Myeloablative Chemotherapy Regimen for Non-Cord Blood Unit Recipients with Myeloid Malignancies",{"intervention":1225,"totalTrials":93,"cells":1227},{"EARLY_PHASE1":1228,"PHASE1":1230,"PHASE2":1232,"PHASE3":1234,"PHASE4":1236,"NA":1238},{"trials":1229,"activeCount":97},[],{"trials":1231,"activeCount":97},[],{"trials":1233,"activeCount":97},[],{"trials":1235,"activeCount":97},[],{"trials":1237,"activeCount":97},[],{"trials":1239,"activeCount":97},[1240],{"nctId":1212,"briefTitle":1213,"status":449,"phases":1241,"primaryCompletion":1215,"completion":1215,"start":1216,"enrollment":1217,"conditions":1242,"interventions":1243},[],[1219,1220,1221,1222,1223],[1197,1225],{"intervention":1245,"totalTrials":93,"cells":1246},"FAM Therapy",{"EARLY_PHASE1":1247,"PHASE1":1249,"PHASE2":1251,"PHASE3":1253,"PHASE4":1255,"NA":1257},{"trials":1248,"activeCount":97},[],{"trials":1250,"activeCount":97},[],{"trials":1252,"activeCount":97},[],{"trials":1254,"activeCount":97},[],{"trials":1256,"activeCount":97},[],{"trials":1258,"activeCount":97},[1259],{"nctId":1260,"briefTitle":1261,"status":449,"phases":1262,"primaryCompletion":1263,"completion":1263,"start":615,"enrollment":1192,"conditions":1264,"interventions":1266},"NCT03072849","Early Detection and Management of Bronchiolitis Obliterans Syndrome Following Pediatric Hematopoietic Stem Cell Transplantation",[],"2020-09-01",[1265],"Bronchiolitis Obliterans Syndrome",[1245],{"intervention":1268,"totalTrials":93,"cells":1269},"adrenocorticotropin hormone",{"EARLY_PHASE1":1270,"PHASE1":1272,"PHASE2":1274,"PHASE3":1276,"PHASE4":1278,"NA":1280},{"trials":1271,"activeCount":97},[],{"trials":1273,"activeCount":97},[],{"trials":1275,"activeCount":97},[],{"trials":1277,"activeCount":97},[],{"trials":1279,"activeCount":97},[],{"trials":1281,"activeCount":97},[1282],{"nctId":1283,"briefTitle":1284,"status":716,"phases":1285,"primaryCompletion":37,"completion":37,"start":1286,"enrollment":1287,"conditions":1288,"interventions":1290},"NCT01367964","Prevention of West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)",[90],"2011-07",28,[1289],"West Syndrome",[1268],{"intervention":1292,"totalTrials":93,"cells":1293},"Oral Clindamycin",{"EARLY_PHASE1":1294,"PHASE1":1296,"PHASE2":1298,"PHASE3":1300,"PHASE4":1302,"NA":1304},{"trials":1295,"activeCount":97},[],{"trials":1297,"activeCount":97},[],{"trials":1299,"activeCount":97},[],{"trials":1301,"activeCount":97},[],{"trials":1303,"activeCount":97},[],{"trials":1305,"activeCount":97},[1306],{"nctId":1307,"briefTitle":1308,"status":667,"phases":1309,"primaryCompletion":1310,"completion":1310,"start":1311,"enrollment":1312,"conditions":1313,"interventions":1317},"NCT01498744","Randomized Controlled Trial of Antibiotics in the Management of Children With Community-Acquired Abscess",[90],"2013-02","2010-02",53,[1314,1315,1316],"Abscess Soft Tissue","Methicillin-resistant Staphylococcus Aureus (MRSA) Infection","Skin Abscess",[1292]]